Creatine + Whey Protein for Sarcopenia
Trial Summary
What is the purpose of this trial?
The primary purpose of this research is to compare the effects of creatine monohydrate and/or whey protein supplementation during the first 10 weeks of a 20-week resistance-band training program on measures of body composition (whole-body lean tissue mass, total body water), arm and leg muscle thickness, upper- and lower-body muscle performance (i.e., strength, endurance) and functional ability (walking speed, balance). A secondary purpose of this research is to examine the effects of supplementation cessation (i.e., no creatine and/or whey protein supplementation) during the final 10 weeks of the 20-week resistance-band training program on these measures.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot be taking creatine or whey protein before starting the study.
What data supports the effectiveness of the treatment Resistance-band Training combined with Creatine and Whey Protein for Sarcopenia?
Is creatine and whey protein safe for humans?
How does the treatment of creatine and whey protein for sarcopenia differ from other treatments?
The combination of creatine and whey protein for sarcopenia is unique because it leverages both supplements' ability to enhance muscle mass and strength, especially when combined with resistance training. Creatine is known to boost muscle energy, while whey protein provides high-quality protein that supports muscle repair and growth, making this combination potentially more effective than using either supplement alone.69101112
Research Team
Darren Candow
Principal Investigator
University of Regina
Eligibility Criteria
This trial is for individuals with sarcopenia, a condition characterized by loss of muscle mass and strength. Participants should be interested in undergoing a 20-week resistance-band training program and are willing to take creatine monohydrate and/or whey protein supplements.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 20-week resistance-band training program with creatine and/or whey protein supplementation during the first 10 weeks
Supplementation Cessation
Participants cease creatine and/or whey protein supplementation during the final 10 weeks of the resistance-band training program
Follow-up
Participants are monitored for safety and effectiveness after the training program
Treatment Details
Interventions
- Resistance-band Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Regina
Lead Sponsor
Iovate Health Sciences International Inc
Industry Sponsor